AtaiBeckley Inc. (NASDAQ:ATAI) stock jumps as FDA staffing guidance spotlights BPL-003’s two-hour edge
NEW YORK, July 14, 2026, 15:10 (EDT) AtaiBeckley Inc. (NASDAQ:ATAI) shares climbed 15.6% to about $5.75 in Tuesday afternoon trading as investors weighed final U.S. Food and Drug Administration…
Read the full articleYou might also wanna read
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
July 16 (Reuters) - AtaiBeckley shares soared 50% premarket on Thursday after a report that Eli Lilly was in talks to acquire the psychedeli
Pharma giant Eli Lilly enters psychedelics space with AtaiBeckley takeover
AtaiBeckley stock rose more than 55% in after-hours trading Wednesday The post Pharma giant Eli Lilly enters psychedelics space with AtaiBec
Lilly Announces $2.8 Billion Psychedelics Acquisition
The deal values AtaiBeckley at $6.75 per share, a 26% premium over its previous closing price
Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal
July 16 (Reuters) - Eli Lilly said on Thursday it would buy AtaiBeckley for up to $3.8 billion, entering the race to develop psychedelic tre
Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal
July 16 (Reuters) - Eli Lilly said on Thursday it would buy AtaiBeckley for up to $3.8 billion, entering the race to develop psychedelic tre
Lilly buys into psychedelics with $3.8bn AtaiBeckley deal
Lilly buys into psychedelics with $3.8bn AtaiBeckley deal Phil.Taylor Thu, 16/07/2026 - 12:09
Comments
Sign in to join the conversation.
No comments yet. Be the first.